Vijaya Diagnostic Centre Limited (VIJAYA.BO)
INR 1059.65
(-1.01%)
INR 1059.65
(-1.01%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.9 Billion | 1.64 Billion | 1.57 Billion | 1.29 Billion | 1.06 Billion | 905.27 Million |
| Net Income | 1.18 Billion | 1.13 Billion | 1.47 Billion | 1.12 Billion | 834.27 Million | 653.18 Million |
| Depreciation & Amortization | 569.96 Million | 617.2 Million | 526.86 Million | 504.51 Million | 491.7 Million | 396.26 Million |
| Deferred income taxes | - | -305.95 Million | -417.24 Million | -309.38 Million | -325.79 Million | -230.85 Million |
| Stock-based compensation | 9.31 Million | 7.16 Million | 11.35 Million | 1.95 Million | 4.09 Million | 2.22 Million |
| Change in working capital | -13.93 Million | 90.16 Million | -66.85 Million | -45.65 Million | -32.45 Million | 7.97 Million |
| Other non-cash items | 1.33 Billion | 102.44 Million | 52.02 Million | 23.69 Million | 89.29 Million | 76.49 Million |
| Investing Cash Flow | -1.49 Billion | -1.09 Billion | -1.23 Billion | -1.29 Billion | -306.22 Million | -898.46 Million |
| Investments in PPE | -879.63 Million | -1.24 Billion | -1.22 Billion | -321.3 Million | -475.47 Million | -610.39 Million |
| Acquisitions | -1.44 Billion | 2.54 Million | -17 Million | 9.03 Million | 100.6 Million | 19.13 Million |
| Investment purchases | - | -800.38 Million | -247.69 Million | -1.3 Billion | - | -313.59 Million |
| Sales/Maturities of investments | 824.68 Million | 886.85 Million | 120.78 Million | 275.31 Million | 11.31 Million | - |
| Other Investing Activities | 931.56 Million | 63.69 Million | 136.77 Million | 47.51 Million | 57.34 Million | 6.39 Million |
| Financing Cash Flow | -445.49 Million | -419.12 Million | -305.72 Million | -487.69 Million | -295.42 Million | -71.77 Million |
| Debt repayment | -373.73 Million | -6.34 Million | -38.36 Million | -282.6 Million | -89.38 Million | -94.67 Million |
| Dividends payments | -102.26 Million | -102.11 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 30.5 Million | 11.59 Million | - | - | - | - |
| Other Financing Activities | 30.5 Million | -322.25 Million | -267.35 Million | -205.09 Million | -206.04 Million | 22.9 Million |
| Accounts receivables | -45.66 Million | 494 Thousand | -30.66 Million | 9.18 Million | 7.03 Million | -26.54 Million |
| Accounts payables | 33.44 Million | 69.76 Million | -3.09 Million | 4.67 Million | -620 Thousand | 41.8 Million |
| Inventory | -23.04 Million | 22.28 Million | -16.32 Million | 1.28 Million | -5.95 Million | 2.43 Million |
| Other working capital | 21.32 Million | -2.37 Million | -16.77 Million | -60.81 Million | -32.91 Million | -9.72 Million |
| Cash at beginning of period | 241.76 Million | 110.49 Million | 66.85 Million | 555.68 Million | 96.21 Million | 161.17 Million |
| Cash at end of period | 730.77 Million | 241.76 Million | 110.49 Million | 66.85 Million | 555.69 Million | 96.21 Million |
| Capital Expenditure | -879.63 Million | -1.24 Billion | -1.22 Billion | -321.3 Million | -475.47 Million | -610.39 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 489 Million | 131.27 Million | 43.64 Million | -488.82 Million | 459.48 Million | -64.96 Million |
| Free Cash Flow | 1.02 Billion | 397.69 Million | 356.5 Million | 975.05 Million | 585.65 Million | 294.88 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 313.45 Million | 1.18 Billion | 334.5 Million | 258.48 Million | 333.22 Million | 262.03 Million |
| Depreciation & Amortization | - | 569.96 Million | - | 145.41 Million | 136.87 Million | 124.7 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 9.31 Million | - | - | - | - |
| Change in working capital | - | -13.93 Million | - | - | - | - |
| Other non-cash items | -313.45 Million | 1.33 Billion | -334.5 Million | -258.48 Million | -333.22 Million | -262.03 Million |
| Investing Cash Flow | - | -1.49 Billion | - | - | - | - |
| Investments in PPE | - | -879.63 Million | - | - | - | - |
| Acquisitions | - | -1.44 Billion | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 824.68 Million | - | - | - | - |
| Other Investing Activities | - | 931.56 Million | - | - | - | - |
| Financing Cash Flow | - | -445.49 Million | - | - | - | - |
| Debt repayment | - | -373.73 Million | - | - | - | - |
| Dividends payments | - | -102.26 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 30.5 Million | - | - | - | - |
| Other Financing Activities | - | 30.5 Million | - | - | - | - |
| Accounts receivables | - | -45.66 Million | - | - | - | - |
| Accounts payables | - | 33.44 Million | - | - | - | - |
| Inventory | - | -23.04 Million | - | - | - | - |
| Other working capital | - | 21.32 Million | - | - | - | - |
| Cash at beginning of period | - | 241.76 Million | - | 232.21 Million | -101 Million | 241.76 Million |
| Cash at end of period | - | 730.77 Million | - | 258.48 Million | 232.21 Million | 262.03 Million |
| Capital Expenditure | - | -879.63 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 489 Million | - | 26.27 Million | 333.22 Million | 20.26 Million |
| Free Cash Flow | - | 1.02 Billion | - | 258.48 Million | 333.22 Million | 262.03 Million |
8107
3382
TNP
0I7E
4565
3738